Drug class
Aminoglycoside antibacterial; 30S ribosomal subunit inhibitor
Mechanism of action
Binds the 30S ribosomal subunit, interfering with initiation and causing misreading of mRNA, which leads to production of abnormal proteins and bactericidal activity against susceptible aerobic bacteria.
General use cases
- Treatment of serious infections caused by susceptible Gram-negative aerobic bacteria with parenteral formulations where authorised
- Topical ophthalmic or otic formulations are used for selected superficial bacterial infections of the eye or ear; route-specific products and indications are not interchangeable
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
